A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells.
We have developed a strategy to identify putative tissue-type plasminogen activator (tPA)receptors present in pancreatic cancer cells by affinity capture with tPA-Sepharose followed by 2-DE and MALDI-MS PMF. Proteins pulled down from either total lysates or raft membrane fractions were characterized and compared with those from a total lysate of an endothelial cell line (HUVEC) to identify pancreas-restricted tPA receptors. A total of 31 proteins were found by this approach, including annexin A2, already described as a tPA receptor in pancreas and endothelial cells, other proteins acting as tPA receptors (i.e., enolase, cytokeratins 8 and 18) in other tissues, and additional proteins not previously identified as candidate tPA receptors. Confirmation of the results was performed for some of these proteins using immunoblotting. These studies are the basis for further functional analyses on the role of these proteins in the biological effects of tPA.
Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.
Oriol
O
Roda
Cristina
C
Chiva
Gemma
G
Espuña
Hans-J
HJ
Gabius
Francisco X
FX
Real
Pilar
P
Navarro
David
D
Andreu
D017306:Annexin A2 / Q000378:metabolism; D006801:Humans; D010190:Pancreatic Neoplasms / Q000737:chemistry / Q000378:metabolism*; D040901:Proteomics; D011956:Receptors, Cell Surface / Q000378:metabolism* / Q000502:physiology; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D010959:Tissue Plasminogen Activator / Q000378:metabolism*
D017306:Annexin A2; D011956:Receptors, Cell Surface; D010959:Tissue Plasminogen Activator